Ampio Pharmaceuticals reaches settlement in principle in certain legal actions
Share- Nishadil
- January 12, 2024
- 0 Comments
- 0.26 minutes read
- 23 Views
Ampio Pharmaceuticals ( NYSE: AMPE ) said it has reached settlement s in principle in the pending securities fraud class action and the pending consolidated derivative actions in the United States District Court for the District of Colorado. The company added the settlements are subject to certain conditions. AMPE currently expects the amount to be paid in both settlements, including related defense costs, which will be covered by, and within the limits of, its D&O insurance policy. More on Ampio Pharmaceuticals Financial information for Ampio Pharmaceuticals
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on
